Sunlenca 463.5 mg/1.5 mL (309 mg/mL) injection Images

Generic Name: lenacapavir

This medication has been identified as Sunlenca 463.5 mg/1.5 mL (309 mg/mL) injection. It is supplied by Gilead Sciences, Inc.

Sunlenca is used in the treatment of HIV Infection and belongs to the drug class miscellaneous antivirals. Sunlenca 463.5 mg/1.5 mL (309 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Sunlenca

Generic Name

lenacapavir

Strength

463.5 mg/1.5 mL (309 mg/mL) injection

Availability

Prescription only

Drug Class

Miscellaneous antivirals

CSA Schedule

Not a controlled drug

Labeler / Supplier

Gilead Sciences, Inc.

National Drug Code (NDC)

61958-3002

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer